Drug-eluting stent

We evaluated the long-term outcomes of multivessel compared with single-vessel percutaneous coronary intervention with Xience V everolimus-eluting stents in real-world patients.

We evaluated the long-term...

08/27/2019

Journal of Invasive Cardiology

A Case of Very Late Stent Thrombosis 11 Years After Drug-Eluting Stent Implantation

07/23/2019

;

Rajesh Vijayvergiya , MD, DM;

Eleven years after DES implantation, a patient presented with AMI despite continued dual-antiplatelet therapy. Coronary angiography revealed total occlusion of the proximal LAD.

Eleven years after DES...

07/23/2019

Journal of Invasive Cardiology

Original Contribution

One-Year Clinical Outcomes of Forty-Eight Millimeter Everolimus-Eluting Stent Implanted in Very Long Lesions: A Propensity-Matched Comparison (The FREIUS Study)

03/30/2018

Andrea Cuculo , MD;

Rossella Fattori , MD;

Pietro Sangiorgio , MD;

Rosario Parisi , MD;

Antonio Centola , MD;

Matteo Vercellino , MD;

Giovanni Longo , MD;

Gianfranco Pistis , MD;

Simone Biscaglia , MD;

Antonio Ruggiero , MD;

Paolo Nicola Marino , MD;

Gianluca Campo , MD;

Alfonso Ielasi , MD;

Carlo Di Mario , MD, PhD, FESC, FACC, FRCP;

Matteo Tebaldi , MD;

Gioel Gabrio Secco , MD;

The aim of our study was to evaluate the safety, feasibility, and cost effectiveness of a 48 mm everolimus-eluting stent (EES) during treatment of very long coronary lesions.

The aim of our study was to...

03/30/2018

Journal of Invasive Cardiology

Commentary

Comparing Drug-Eluting Stents to Bare-Metal Stents for Saphenous Vein Graft Lesion PCI

11/30/2016

Subhash Banerjee , MD, FSCAI;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

The authors offer their insights into the article on stenting saphenous vein graft lesions by Mosleh, et al.

The authors offer their insights...

11/30/2016

Journal of Invasive Cardiology

Original Contribution

Comparison of Drug-Eluting Stents With Bare-Metal Stents for PCI of Saphenous Vein Graft Lesions: Systematic Review and Meta-Analysis

11/15/2016

Michael E. Farkouh , MD, MSc;

Wassim Mosleh , MBBCh, BAO, MD;

Sumeet Gandhi , MD;

Mohamed Elsiddig , MBBCh, BAO;

Jon David Schwalm , MD, MSc;

The results of this large meta-analysis suggest that patients with DES (n = 39,213) in comparison with BMS implantation (n = 26,461) for PCI to SVG lesions had lower MACE, all-cause mortality, and TVR rates, without a significant reduction in...

The results of this large...

11/15/2016

Journal of Invasive Cardiology

Original Contribution

Characteristics of Late-Acquired Incomplete Stent Apposition: A Comparison With First-Generation and Second-Generation Drug-Eluting Stents

12/15/2015

Junya Ako , MD, PhD;

Yasuhiro Honda , MD;

Peter J. Fitzgerald , MD, PhD;

Katsuhisa Waseda , MD, PhD;

Teruyoshi Kume , MD, PhD;

This study investigated the morphometric parameters of late-acquired incomplete stent apposition after use of Cypher SES, Taxus PES, and Resolute ZES.

This study investigated the...

12/15/2015

Journal of Invasive Cardiology

Original Contribution

Twelve-Month Outcomes With a Bioresorbable Everolimus-Eluting Scaffold: Results of the ESHC-BVS Registry at Two Australian Centers

11/15/2015

Daniel Robaei , MBBS;

Liam Back , MBBS;

Sze-Yuan Ooi , MD;

Mark Pitney , MBBS;

Nigel Jepson , MBBS;

The Absorb BVS is a relatively new type of coronary stent designed to provide temporary vessel scaffolding following percutaneous coronary intervention. We report 12-month clinical data on the Absorb BVS from a real-world registry in order to...

The Absorb BVS is a relatively...

11/15/2015

Journal of Invasive Cardiology

Original Contribution

Clinical Impact of Second-Generation Everolimus-Eluting Stents Compared With First-Generation Drug-Eluting Stents in Diabetic Patients Undergoing Multivessel Percutaneous Coronary Intervention

05/29/2015

Lakshmana Pendyala , MD;

Joshua Loh , MD;

William O. Suddath , MD;

Hironori Kitabata , MD;

Rebecca L. Torguson , BS, MPH;

Sa'ar Minha , MD;

Fang Chen , PhD;

Ron Waksman , MD;

Lowell F. Satler , MD;

Augusto D. Pichard , MD, FACC, FSCAI;

This study aimed to evaluate the safety and efficacy of everolimus-eluting stent (EES) use compared with first-generation drug-eluting stent (DES) use in diabetic patients undergoing multivessel percutaneous coronary intervention. In diabetic...

This study aimed to evaluate the...

05/29/2015

Journal of Invasive Cardiology

Original Contribution

Thin-Strut Drug-Eluting Stents are More Favorable for Severe Calcified Lesions After Rotational Atherectomy Than Thick-Strut Drug-Eluting Stents

01/29/2014

Yasuharu Lee , MD;

Akihiro Tanaka , MD;

Naoki Mori , MD;

Takahiro Yoshimura , MD;

Daisuke Nakamura , MD;

Masayuki Taniike , MD, PhD;

Nobuhiko Makino , MD, PhD;

Yasuyuki Egami , MD;

Ryu Shutta , MD;

Jun Tanouchi , MD, PhD;

Masami Nishino , MD, PhD;

There are few studies of drug-eluting stent (DES) implantation for severely calcified lesions, especially regarding long-term results and hemodialysis patients. This study clarifies the factors, including DES strut thickness, that affect the...

There are few studies of...

01/29/2014

Journal of Invasive Cardiology